Vincerx Pharma Inc reports results for the quarter ended in January - Earnings Summary

Vincerx Pharma

08/08/2024 23:47

* Vincerx Pharma Inc  VINC.OQ  reported a quarterly adjusted
loss
of 5 cents​​ per share for the quarter ended in January, higher
than the same quarter last year, when the company reported EPS
of -52 cents.  The mean expectation of three analysts for the
quarter was for a loss of 20 cents per share. Wall Street
expected results to range from -24 cents to -17 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Vincerx Pharma Inc's reported EPS for the quarter was a
loss
of 5 cents​.
    * The company reported a quarterly loss of $1.81 million.
    * Vincerx Pharma Inc shares had fallen by 31.6% this
quarter and
lost 53.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 8.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Vincerx Pharma
Inc is $7.00 
This summary was machine generated from LSEG data August 8 at
10:46 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.20          -0.05          Beat
 Mar. 31 2024      -0.23          -0.58          Missed
 Dec. 31 2023      -0.37          -0.23          Beat
 Sep. 30 2023      -0.46          -0.46          Met